thrombopoietin receptor agonist (TPO-RA) + Cyclosporine + ROMIPLOSTIM for anemia, aplastic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Apr 2026: Trial registered, NCT07558434

The trials

NCT07558434: CsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAA

State
Not started
Phase
Phase 2
People
43 planned
Started
Apr 2026
Primary completion
Dec 2028
Arms
CsA+EPAG/HPAG+Romiplostim N01
Results
None posted
  1. 30 Apr 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.